Xilio Therapeutics Inc (XLO)
0.7740 -0.0545 (-6.58%) 14:48 ET [NASDAQ]
0.7730 x 24 0.7900 x 8
Realtime by (Cboe BZX)
0.7730 x 24 0.7900 x 8
Realtime 0.8285 unch (-) 06:01 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | XLO | KLRS | FBLG | ||
| Company | Xilio Therapeutics Inc | Kalaris Therapeutics Inc | Fibrobiologics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.8040 | 6.61 | 1.2000 | ||
| High | 0.8400 | 7.33 | 1.2691 | ||
| Low | 0.7627 | 6.53 | 1.0800 | ||
| Last | 0.7740 | 6.63 | 1.1150 | ||
| Change | -0.0545 | -0.07 | -0.1050 | ||
| % Change | -6.58% | -1.04% | -8.61% | ||
| Volume | 154,515 | 48,863 | 133,673 | ||
| 20-Day Average Volume | 208,330 | 51,603 | 250,407 | ||
| Previous Close | 0.8285 | 6.70 | 1.2200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.7341 | 7.10 | 1.0229 | ||
| 20-Day Raw Stochastic | 63.75% | 32.14% | 46.09% | ||
| 20-Day Relative Strength | 49.03% | 40.64% | 49.30% | ||
| Weighted Alpha | -57.95 | -59.26 | -66.97 | ||
| Today's Opinion | 72% Sell | 100% Sell | 56% Sell | ||
| Previous Opinion | 72% Sell | 100% Sell | 56% Sell | ||
| Last Month's Opinion | 88% Sell | 80% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.15% since 04/21/25 | +2.90% since 04/21/25 | -19.11% since 04/21/25 | ||
| Low | 0.7600 on 04/28/25 | 6.41 on 04/22/25 | 1.0800 on 04/28/25 | ||
| High | 0.8600 on 04/22/25 | 7.33 on 04/28/25 | 1.5300 on 04/22/25 | ||
| 1-Month | |||||
| %Chg | +3.62% since 03/28/25 | -20.91% since 03/28/25 | +17.51% since 03/28/25 | ||
| Low | 0.6200 on 04/07/25 | 5.86 on 04/07/25 | 0.7626 on 04/09/25 | ||
| High | 0.8600 on 04/22/25 | 8.78 on 03/31/25 | 1.5300 on 04/22/25 | ||
| 3-Month | |||||
| %Chg | +4.50% since 01/28/25 | -29.88% since 01/28/25 | -29.79% since 01/28/25 | ||
| Low | 0.6200 on 04/07/25 | 5.86 on 04/07/25 | 0.7626 on 04/09/25 | ||
| High | 1.7000 on 02/12/25 | 12.90 on 03/20/25 | 2.0000 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | -24.95% since 10/28/24 | -65.38% since 10/28/24 | -60.41% since 10/28/24 | ||
| Low | 0.6200 on 04/07/25 | 5.86 on 04/07/25 | 0.7626 on 04/09/25 | ||
| High | 1.7000 on 02/12/25 | 24.15 on 11/04/24 | 3.8900 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,191 | 35,707 | 33,526 | ||
| Shares Outstanding, K | 51,775 | 5,043 | 38,263 | ||
| Annual Sales | 6,340,000 | 0 | 0 | ||
| Annual Net Income | -58,240,000 | -58,770,000 | -11,160,000 | ||
| Last Quarter Sales | 1,720,000 | 0 | 0 | ||
| Last Quarter Net Income | -13,090,000 | -18,270,000 | -3,100,000 | ||
| 60-Month Beta | -0.25 | 0.68 | 0.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 03/11/25 | -0.92 on 11/12/24 | -0.09 on 03/31/25 | ||
| Latest Earnings Date | 05/13/25 | 05/12/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||